Innovation

Compositions for oral administration for the treatment of interferon-responsive disorders

Institute for Hepatitis and Virus Research
posted on 02/15/2009

Compositions and methods of treatment of interferon-responsive disorders are provided wherein the methods, for example, comprise orally administering a composition which comprises a therapeutically effective amount of at least one alkylated imino sugar having an alkylated side chain, and a pharmaceutically acceptable carrier.


Innovation Details
 

Detailed Description

A method of treatment of a pathophysiological condition by induction of an innate host defense pathway, comprising orally administering a composition which comprises a therapeutically effective amount of at least one alkylated imino sugar having an alkylated side chain, and a pharmaceutically acceptable carrier, wherein symptoms of the condition are controlled.

File Number: 05-1C 

Disease: Infectious Diseases


IP Protection


License Online

This innovation currently is not available for online licensing. Please contact Ethan Byler at Institute for Hepatitis and Virus Research for more information.

Request more info via email request more info
People

Case Manager:

Ethan Byler Ethan Byler

Innovations (11)


Download Technology Brief (PDF)


Followed By

Follow this innovation



No one is following this innovation.

Organization
Profile
Related Tags

Find more innovations


February 11, 2009

8,771 members 16,654 innovations 159 organizations

Browse

Alan Thomas, Director, UChicagoTech

"The iBridge Network has opened up new avenues for innovations at UChicagoTech. Relationships between researchers from other universities or industry can be built and strengthened, while investors can find new technologies to advance. "  read more...